iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Benchmarks decline further; IT shares extend losses

20 Jan 2022 , 10:30 AM

The key equity benchmarks declined further in morning trade. The Nifty was trading below the 17,850 mark. IT shares declined for the fifth consecutive session.

At 10:26 IST, the barometer index, the S&P BSE Sensex, was down 398.37 points or 0.66% to 59,700.45. The Nifty 50 index lost 100.65 points or 0.56% to 17,837.75.

In the broader market, the S&P BSE Mid-Cap index rose 0.09% while the S&P BSE Small-Cap index added 0.29%.

The market breadth was positive. On the BSE, 1756 shares rose and 1384 shares fell. A total of 109 shares were unchanged.

Results Today:

Hindustan Unilever (down 0.63%), Asian Paints (down 0.83%), Bajaj Finserv (down 0.96%), Bajaj Holdings & Investment (up 0.78%), Havells India (down 0.52%), Biocon (down 0.68%), Mphasis (up 0.17%), Persistent Systems (up 1.88%), PNB Housing Finance (up 1.69%), Hatsun Agro Product (down 0.10%), Container Corporation Of India (down 0.95%), Cyient (down 0.32%), Century Textiles & Industries (up 0.69%), Bank of Maharashtra (up 0.93%), Orient Electric (down 0.14%), Dodla Dairy (down 0.07%), Shoppers Stop (down 0.40%) and VST Industries (down 0.11%) will announce their quarterly earnings today.

Buzzing Index:

The Nifty Pharma index fell 0.76% to 13,578.50, extending losses for third day. The index has declined 3.36% in five sessions.

Gland Pharma (down 1.78%), Lupin (down 1.45%), Divis Labs (down 1.23%), Cipla (down 0.85%), Laurus Labs (down 0.83%), Sun Pharma (down 0.82%), Dr. Reddys Labs (down 0.66%), Ipca Laboratories (down 0.60%) and Strides Pharma (down 0.58%) declined.

Concurrently, Granules India (up 2.05%), Pfizer (up 0.74%), Torrent Pharma (up 0.12%) and Alkem Laboratories (up 0.11%) outperformed.

Stocks in Spotlight:

CEAT fell 3.65% to Rs 1092.10. The tyre maker posted a consolidated net loss of Rs 20.18 crore in Q3 FY22 as compared with net profit of Rs 132.34 crore in Q3 FY21. Total income rose to Rs 2416.44 crore from Rs 2225.30 crore.

Dhunseri Tea & Industries added 4.44% to Rs 319.65. The company has entered into an agreement for sale dated 19 January 2022 with Warren Tea for acquisition of Balijan North Tea Estate.

Glenmark Pharma shed 0.84% to Rs 494.30. The company said that its subsidiary, Glenmark Specialty S.A, has entered into an exclusive licensing agreement with Lotus International for commercializing its nasal spray Ryaltris in Singapore, Hong Kong and Vietnam.

COVID-19 Update:

In last 24 hours, India registered 3,17,532 new COVID-19 infections in a day, according to the Union Health Ministry data on Thursday. The country reported 491 new deaths taking the death toll to 4,87,693. The country recorded 2,23,990 recoveries, taking the total number of recoveries to 3,58,07,029. The active cases comprise 5.03% of the total infections, while the national COVID-19 recovery rate has decreased to 93.69%, the ministry said.

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.